









Markets
/
Stocks
/
nasdaq-sskn
/

STRATA Skin Sciences Inc

SSKN

1.070USD

+0.040+3.88%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

5.64MMarket Cap

LossP/E TTM



STRATA Skin Sciences Inc

1.070

+0.040+3.88%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of STRATA Skin Sciences Inc

Currency: USD Updated: 2026-02-05

Key Insights

STRATA Skin Sciences Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 117 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 7.40.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

STRATA Skin Sciences Inc's Score

Industry at a Glance

Industry Ranking

117 / 205

Overall Ranking

294 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

STRATA Skin Sciences Inc Highlights

StrengthsRisks

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Growing

The company is in a growing phase, with the latest annual income totaling USD 33.56M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 33.56M.

Overvalued

The company’s latest PE is -0.39, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.56M shares, decreasing 4.02% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 101.53K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 16.43.

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

7.400

Target Price

+478.13%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-05

The current financial score of STRATA Skin Sciences Inc is 6.67, ranking 137 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 6.93M, representing a year-over-year decrease of 21.23%, while its net profit experienced a year-over-year decrease of 23.56%.

Score

Industry at a Glance

Previous score

6.67

Change



Financials

5.73

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.52

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.84

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.15

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

STRATA Skin Sciences Inc's Company Valuation

Currency: USD Updated: 2026-02-05

The current valuation score of STRATA Skin Sciences Inc is 7.23, ranking 109 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.39, which is 0.00% below the recent high of -0.39 and -2021.32% above the recent low of -8.32.

Score

Industry at a Glance

Previous score

7.23

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 117/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-05

The current earnings forecast score of STRATA Skin Sciences Inc is 9.00, ranking 6 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 7.40, with a high of 10.80 and a low of 4.00.

Score

Industry at a Glance

Previous score

9.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

7.400

Target Price

+618.45%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

STRATA Skin Sciences Inc

SSKN

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-05

The current price momentum score of STRATA Skin Sciences Inc is 4.82, ranking 186 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.27 and the support level at 0.89, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.31

Change

0.51

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.038

Sell

RSI(14)

34.938

Neutral

STOCH(KDJ)(9,3,3)

16.233

Oversold

ATR(14)

0.085

High Vlolatility

CCI(14)

-161.418

Sell

Williams %R

80.000

Sell

TRIX(12,20)

-0.488

Sell

StochRSI(14)

24.827

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.134

Sell

MA10

1.183

Sell

MA20

1.237

Sell

MA50

1.304

Sell

MA100

1.529

Sell

MA200

1.876

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-05

The current institutional shareholding score of STRATA Skin Sciences Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 43.55%, representing a quarter-over-quarter decrease of 11.71%. The largest institutional shareholder is James Simons, holding a total of 101.53K shares, representing 1.72% of shares outstanding, with 29.37% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Accelmed Growth Partners Management Ltd

1.44M

22NW, LP

537.00K

Nantahala Capital Management, LLC

403.92K

Lincoln Alternative Strategies LLC

365.85K

Renaissance Technologies LLC

Star Investors

101.53K

+3.57%

Geode Capital Management, L.L.C.

18.14K

-0.31%

The Vanguard Group, Inc.

Star Investors

23.55K

-72.18%

Susquehanna International Group, LLP

12.43K

Rubinstein (Samuel)

10.77K

-45.79%

Risk Assessment

Currency: USD Updated: 2026-02-05

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of STRATA Skin Sciences Inc is 1.49, ranking 189 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.33. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.